MS Pharma and Polpharma Biologics Partner to Expand Biosimilar Access in MENA
BioPharm International,
Dilok - stock.adobe.com MS Pharma, an Amman, Jordan-headquartered biosimilar production and distribution company in the Middle…
Guselkumab brings active psoriatic arthritis into ‘stringent’ control through 2 years
Healio.com,
Guselkumab for psoriatic arthritis led to major improvements in joint disease activity, complete skin clearance and other “string…
Guselkumab Achieves Durable Control of Key Psoriatic Arthritis Endpoints
HCP Live,
Christopher T. Ritchlin, MD, MPH Credit: University of Rochester The efficacy of guselkumab across stringent disease endpoints…